# Ketamine for the Treatment for Alcohol Use Disorder in the ED

> **NCT05661669** · PHASE2 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05661669
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-01
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-08-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** After months of screening, we screened 175 individuals, only 3 were eligible, 2 declined, and 1 was moved to a different floor before study activities were able to take place.
- **Last updated:** 2025-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05661669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05661669, "Ketamine for the Treatment for Alcohol Use Disorder in the ED". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05661669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*